Navigation Links
NVHR: New JAMA Article Underscores Urgent Need for Congress to Act on Viral Hepatitis Detection, Management Funding

WASHINGTON, Nov. 11 /PRNewswire-USNewswire/ -- An article running in the new issue of the Journal of the American Medical Association, "Silent Epidemic of Viral Hepatitis May Lead to Boom in Serious Liver Disease," underscores the urgent need for Congress to act on new bipartisan legislation, HR 3974, that would increase funding for a comprehensive prevention, research, and medical management referral program for chronic hepatitis B and chronic hepatitis C virus infection afflicting millions of Americans, the National Viral Hepatitis Roundtable (NVHR) said today.

The NVHR is a coalition of more than 150 public, private, and voluntary organizations dedicated to reducing the incidence of infection, morbidity, and mortality from viral hepatitis in the United States through strategic planning, leadership, coordination, advocacy, and research.

"This new JAMA article shines a spotlight on the urgent need for Congress to act on bipartisan legislation to increase funding for comprehensive prevention, research, and medical management of chronic liver disease," said NVHR Chair Lorren Standt. "Without action, the annual costs of chronic liver disease are projected to triple in less than a generation to at least $85 billion annually and wreak havoc with minority communities, especially African Americans, Latinos, and Asian Americans."

The JAMA article provides a succinct overview of the global nature of hepatitis infection - more than 500 million people worldwide are believed to be infected with hepatitis B or C virus - and its implications for the U.S. health care system. As the complexion of the U.S. population diversifies in the coming decades, the need to address chronic liver disease will intensify. The article also pointedly notes that "shifts in clinical practice and public policy could help prevent viral hepatitis infections and improve outcomes for patients with chronic infection."

Last month, bipartisan legislation, "The Viral Hepatitis and Liver Cancer Control Act," was introduced in the U.S. House of Representatives by Congressman Mike Honda (D-Calif.) and supported by 11 House Members that would support a comprehensive prevention, research, and medical management referral program for chronic hepatitis B and chronic hepatitis C virus infection. The bill would provide an initial $90 million in funding in 2011 - with additional funding thereafter - that will increase the ability of the Centers for Disease Control and Prevention (CDC) to support state health departments in their prevention, immunization and surveillance efforts.

An estimated 5.4 million Americans are infected with chronic hepatitis B or chronic hepatitis C infection - and most individuals are not aware they are infected. Without meaningful detection and treatment programs, hepatitis infection can progress to cirrhosis, liver cancer or liver failure. According to Milliman, the cost of chronic hepatitis C virus infection alone could reach $85 billion annually by 2024. Medicare and Medicaid are projected to absorb a disproportionate share of those costs.

In January 2010, the Institute of Medicine is expected to release a report on viral hepatitis in the United States that outlines strategies for reducing the incidence of viral hepatitis infection and to mitigate complications in those individuals with chronic infections.

SOURCE National Viral Hepatitis Roundtable

SOURCE National Viral Hepatitis Roundtable
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. JAG Media Holdings, Inc. Amends Articles of Incorporation
2. Minerva and Cymbalta Patent Invalidity Evidence Uncovered by Article One Partners Community
3. Particle Beam Radiation Therapy Promising But Unproven for Treating Cancer
4. UCSB researchers develop drug delivery system using nanoparticles and lasers
5. WorldatWork Publishes Axiom Consulting Partners' Article on ‘Planning for the New Normal', an Alternative Approach to Compensation Planning
6. European Urology September issue features Surgery in Motion article
7. American Imaging Management Reacts to New England Journal of Medicine Articles on Diagnostic Imaging
8. Family Circle Magazine Features AmLactin(R) in Article on Managing Dry Skin Associated With Keratosis Pilaris
9. Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
10. Editor-In-Chief of SOBeFiT Magazine, Marta Montenegro, Says Time Magazines Article Why Exercise Wont Make You Thin Sends the Wrong Message
11. Article Now Available: Are Special Orders Draining Your Budgets?
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... Cycling, running, and ... take on extra meaning the morning of February 28, 2016. , That’s when ... Park and thousands will exercise to help children and families at Joe DiMaggio ...
(Date:11/30/2015)... ... November 30, 2015 , ... A ... of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of ... Their study showed that small molecule analogs that target the functions of SecA, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood ... children and adults, according to a new study by researchers at the School of ... Children and Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in ...
(Date:11/30/2015)... ... November 30, 2015 , ... International telepathology consultations can ... and KingMed Diagnostics researchers. Their review of more than 1,500 pathology ... pathologists resulted in significantly altered treatment plans for more than half of the ...
(Date:11/30/2015)... PHILADELPHIA (PRWEB) , ... November 30, 2015 , ... ... Philadelphia-based non-profit promoting breast and prostate cancer education and prevention—is joining forces with ... evening of philanthropy and Hollywood elegance on December 7, 2015 at the Union ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BOCA RATON, Fla. , Nov. 30, ... of Public Research (the Institute) announced today that ... , a medical device start-up company with technology developed ... creation based on publicly-funded research, and bridges early funding ... -based universities and research institutions. ...
(Date:11/30/2015)... Nov. 30, 2015 Baxalta Incorporated ... leader dedicated to delivering transformative therapies to ... conditions, today announced the launch and first ... an extended circulating half-life recombinant factor VIII ... full-length ADVATE [Antihemophilic Factor (Recombinant)]. The treatment ...
(Date:11/30/2015)... Months Ended 30 September 2015 2014RestatedChange%Turnover 545,575 , 518,852 , ... 384,242 , 9.8 Hospital Management Service Income ... (18.3) Medical Insurance Administration Service Income , 2,780 ... and Accessories Sales , 89,645 , 94,580 ... 2,822 , 2,917 , (3.3) Gross ...
Breaking Medicine Technology: